Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An investigator-led clinical study of QRX003 to evaluate its safety and efficacy in a pediatric patient with Peeling Skin Syndrome (PSS).

Next Previous
Trial Profile

An investigator-led clinical study of QRX003 to evaluate its safety and efficacy in a pediatric patient with Peeling Skin Syndrome (PSS).

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 May 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs QRX 003 (Primary)
  • Indications Peeling skin syndrome
  • Focus Adverse reactions; Therapeutic Use

Most Recent Events

  • 21 May 2025 The endpoint is not clear from MR-9442614 whether its Primary endpoint or not hence added into other endpoints column ,Kindly update in future.
  • 14 May 2025 According to Quoin Pharmaceuticals Media Release, the company look forward to expanding this study to include additional pediatric subjects in other countries and to advancing the clinical development of the product for this disease.
  • 14 May 2025 Positive initial clinical results presented in the Quoin Pharmaceuticals Media Release

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top